All Stories

  1. Unlocking Innate Antitumor Immunity by Targeting HLA-Mediated Immune Tolerance

    Article • Communications Biology, February 2026, Springer Science + Business Media

    Dr. Jiansheng Jiang, Dr. Abir K. Panda

  2. Antibodies Unlock the Immune System to Attack Cancer by Blocking Self-Protection Signals

    Article • Cancer Immunology Research, October 2025, American Association for Cancer Research (AACR)

    Dr. Jiansheng Jiang, Dr. Abir K. Panda

  3. Structural insights of anti-MHC-I monoclonal antibodies that block NK cell receptor interactions with tumors

    Article • Structural Dynamics, September 2025, American Institute of Physics

    Dr. Abir K. Panda

  4. Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth

    Article • Cancer Discovery, July 2025, American Association for Cancer Research (AACR)

    Dr. Abir K. Panda

  5. Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis

    Article • European Journal of Immunology, May 2025, Wiley

    Dr. Abir K. Panda

  6. FOXP3 Transcriptionally Activates Fatty Acid Scavenger Receptor CD36 in Tumour‐Induced Treg Cells

    Article • Immunology, December 2024, Wiley

    Dr. Abir K. Panda

  7. Abstract C106: IMPACT restrains immuno-metabolic GCN1 signaling to govern pancreatic cancer metastasis

    Article • Cancer Research, January 2024, American Association for Cancer Research (AACR)

    Dr. Abir K. Panda

  8. Inhibition of TCR-MHC-II interactions abrogates Treg-mediated immune suppression and augments anti-tumor immunity

    Article • The Journal of Immunology, May 2023, Oxford University Press (OUP)

    Dr. Abir K. Panda

  9. Treg cell depletion in adult mice results in activation of antigen-presenting cells prior to fatal autoimmune disease

    Article • The Journal of Immunology, May 2023, Oxford University Press (OUP)

    Dr. Abir K. Panda

  10. Global inhibition of Ly-49/MHC-I interactions by anti-MHC-I augments innate and adaptive immunity against cancer metastasis

    Article • The Journal of Immunology, May 2023, Oxford University Press (OUP)

    Dr. Abir K. Panda

  11. Inhibition of Ly-49/LILRB-MHC-I interactions by anti-MHC-I augments innate and adaptive immunity

    Article • The Journal of Immunology, May 2023, Oxford University Press (OUP)

    Dr. Abir K. Panda

  12. FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer

    Article • Frontiers in Immunology, February 2022, Frontiers

    Dr. Abir K. Panda

  13. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation

    Article • The Journal of Immunology, February 2022, Oxford University Press (OUP)

    Dr. Abir K. Panda

  14. Global inhibition of the interaction of NK inhibitory receptors with MHC-I augments coordinated innate and adaptive immunity against cancer metastasis

    Article • The Journal of Immunology, May 2021, Oxford University Press (OUP)

    Dr. Abir K. Panda

  15. Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients

    Article • Medical Oncology, January 2021, Springer Science + Business Media

    Dr. Abir K. Panda

  16. Inhibition of NK cell-MHCI interactions disrupts immune homeostasis by activation of the IFNγ/IL15 axis resulting in augmentation of anti-tumor immunity

    Article • The Journal of Immunology, May 2019, Oxford University Press (OUP)

    Dr. Abir K. Panda

  17. Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis

    Article • Scientific Reports, March 2019, Springer Science + Business Media

    Dr. Abir K. Panda

  18. Providence of the CD25+ KIR+ CD127− FOXP3− CD8+ T-cell subset determines the dynamics of tumor immune surveillance

    Article • Immunology and Cell Biology, August 2018, Wiley

    Abir Kumar Panda, Dr. Abir K. Panda

  19. CD28 co-stimulation drives memory phenotype (MP) Treg cell and MP CD4+Foxp3− effector T cell homeostatic proliferation.

    Article • The Journal of Immunology, May 2018, Oxford University Press (OUP)

    Dr. Abir K. Panda

  20. Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells

    Article • Scientific Reports, May 2017, Springer Science + Business Media

    Dr. Abir K. Panda

  21. New insights into therapeutic activity and anticancer properties of curcumin

    Article • Journal of Experimental Pharmacology, March 2017, Dove Medical Press

    Abir Kumar Panda, Dr. Abir K. Panda

  22. Cancer-immune therapy: restoration of immune response in cancer by immune cell modulation

    Article • The Nucleus, February 2017, Springer Science + Business Media

    Dr. Abir K. Panda

  23. Role of Proteases in Tumor Immune Evasion

    Article • January 2017, Springer Science + Business Media

    Dr. Abir K. Panda

  24. G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53

    Article • Scientific Reports, September 2016, Springer Science + Business Media

    Dr. Abir K. Panda

  25. Curcumin and tumor immune-editing: resurrecting the immune system

    Article • Cell Division, October 2015, Springer Science + Business Media

    Dr. Abir K. Panda

  26. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu

    Article • Immunology, March 2015, Wiley

    Dr. Abir K. Panda